Bendamustine

CAS No. 16506-27-7

Bendamustine ( SDX105 )

Catalog No. M21612 CAS No. 16506-27-7

Bendamustine for?the treatment of Non-Hodgkin Lymphomas and Chronic Lymphocytic Leukemia.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 41 Get Quote
5MG 65 Get Quote
10MG 110 Get Quote
25MG 245 Get Quote
50MG 385 Get Quote
100MG 575 Get Quote
500MG 1233 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Bendamustine
  • Note
    Research use only not for human use.
  • Brief Description
    Bendamustine for?the treatment of Non-Hodgkin Lymphomas and Chronic Lymphocytic Leukemia.
  • Description
    Bendamustine for?the treatment of Non-Hodgkin Lymphomas and Chronic Lymphocytic Leukemia.
  • Synonyms
    SDX105
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    cancer
  • Indication
    Hodgkin's Disease Lymphoma

Chemical Information

  • CAS Number
    16506-27-7
  • Formula Weight
    358.26
  • Molecular Formula
    C16H21Cl2N3O2
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:72 mg/mL (200.97 mM)
  • SMILES
    Cn1c(CCCC(O)=O)nc2cc(ccc12)N(CCCl)CCCl
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Patekar M B Milunovi V Jakobac K M et al. Bendamustine: an Old Drug in the New Era for Patients with Non-Hodgkin Lymphomas and Chronic Lymphocytic Leukemia[J]. Acta Clinica Croatica 2018 57(3):542-553.
molnova catalog
related products
  • Salbutamol Sulfate

    Salbutamol Sulfate is a short-acting β2-adrenergic receptor agonist with an IC50 of 8.93 μM.

  • Benfotiamine

    Benfotiamine, the lipid-soluble thiamine derivative used as a treatment for diabetic neuropathy.

  • Allatostatin II

    Inhibitors of juvenile hormone synthesis in insects.